Trocars Global Market Report 2023 – By Product (Disposable Trocars, Reposable Trocars, Reusable Trocars, Accessories), By Tip (Bladeless Trocars, Optical Trocars, Bladed Trocars, Blunt Trocars), By Application (General Surgery, Gynaecological Surgery, Urological Surgery, Bariatric Surgery, Other Applications) – Market Size, Trends, And Global Forecast 2023-2032

Electrophysiology devices and equipment are used in the diagnosis and treatment of heart rhythm disorders through electrical activity. The main product types in the electrophysiology devices and equipment are electrophysiology ablation catheters, electrophysiology diagnostic catheters, and electrophysiology lab systems. Electrophysiology ablation catheters measure the electrical activity of the heart and diagnose abnormal heart rhythm. The various monitoring devices involved are electrocardiograph (ECG), electroencephalograph (EEG), electrocorticography (ECoG), electromyography (EMG), electroretinographic (ERG), electrooculography (EOG), Holter monitoring devices, X-ray systems, imaging and 3D mapping systems, and diagnostic electrophysiology catheters that are used in indication analysis of atrioventricular nodal reentry tachycardia (AVERT), Wolff-Parkinson-white syndrome (WPW), atrial flutter, and atrial fibrillation. The various end-users of electrophysiology devices and equipment are used in hospitals, diagnostic centres, and clinics. The global electrophysiology devices and equipment market is segmented - 1) By Product Type: Electrophysiology Ablation Catheters, Electrophysiology Diagnostic Catheters, Electrophysiology Lab Systems 2) By Monitoring Device Type: Electrocardiograph (ECG), Electroencephalograph (EEG), Electrocorticograph (ECoG), Electromyograph (EMG), Electroretinograph (ERG), Electrooculograph (EOG), Holter Monitoring Devices, X-Ray Systems, Imaging and 3D Mapping Systems, Diagnostic Electrophysiology Catheters 3) By Indication Analysis: Atrioventricular Nodal Reentry Tachycardia (AVNRT), Wolff-Parkinson-White Syndrome (WPW), Atrial Flutter, Atrial Fibrillation 4) By End-Users: Hospitals, Diagnostic centers, Clinics The global electrophysiology devices and equipment market size will grow from $5.43 billion in 2022 to $5.94 billion in 2023 at a compound annual growth rate (CAGR) of 9.4%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of the electrophysiology devices and equipment is expected to grow to $8.07 billion in 2027 at a CAGR of 7.9%. An increase in the prevalence rate of cardiovascular diseases (CVD) forms one of the major drivers for the industries operating in the electrophysiology devices and equipment market. CVD cases remain the leading cause of death across the globe, which increases the demand for a quick and effective treatment of the disease, thus increasing the demand for electrophysiology devices. According to the Centers for Disease Control and Prevention (CDC), in 2020, 697,000 people died from heart diseases which was almost 1 in every 5 deaths. By 2030, 12.1 million people in the United States will suffer from atrial fibrillation, which is the most common type of heart arrhythmia. Major players in the electrophysiology devices and equipment market are St. Jude Medical, Boston Scientific Corporation, Abbott Laboratories, GE Healthcare, Philips Healthcare, Biotronik SE & Co. KG, Medtronic Inc., Biosense Webster, Microport Scientific Corporation, and Japan Lifeline Co. Lack of uniformity in the regulations governing the electrophysiology devices and equipment industry sometimes restricts the companies in the market from expanding globally, thereby hampering the market’s growth. The impact of individual country regulatory requirements can have huge implications for the availability of new electrophysiology devices and equipment. According to regulations in a few geographies, the manufacturers are required to conduct clinical trials (premarket and/or post-market) be either in whole or in part within a country. However, in markets such as Brazil, Japan, India, and China where local regulations are still in the nascent stage, the cost to run the trials is incurred by the manufacturers. For example, trials for devices like cardiac rhythm management (CRM) in multiple countries have less merit and do not reflect the true test results as it becomes difficult for the manufacturers to provide sufficient devices to run tests. To increase the profit margins and sales, the companies operating in the Electrophysiology (EP) devices and equipment industry are coming up with new technologies aimed towards improving EP mapping and localization technology. EP mapping is a procedure used to diagnose the origins of abnormal heart rhythms. This procedure uses an electrically sensitive catheter. With improved mapping technologies it becomes easy to detect and locate abnormalities in the heart. For example, in June 2020, Boston Scientific launched its DIRECTSENSE™ technology for monitoring the effect of radiofrequency energy delivery during the cardiac ablation procedure. The Reuse of a single-use device (SUD) is permitted by The Medicines and Healthcare products Regulatory Agency (MHRA) may impact the electrophysiology devices and equipment market growth as few of the products within the market may be reused. The MHRA allows the reuse of electrophysiology catheters, however, the device should be adherent to the medical devices directive and should have a CE mark. The reuse or reprocessing of electrophysiology catheters by electrophysiology (EP) laboratories in the US help in reducing the costs of these devices and lessening the environmental burden of the discarded bio-waste materials. As there is no clear regulation on reuse in developing nations such as Africa., Asia, Eastern Europe, Central America, and South America, the electrophysiology devices and equipment market may face a few challenges. In September 2021, Boston Scientific, a company operating in electrophysiology devices and equipment acquired Lumenis for a deal amount of $1.07 billion. With this acquisition, Boston scientific company expands its portfolio in the US and Japan. Lumenis is a medical equipment company and a technology company based in Israel. North America was the largest region in global electrophysiology devices and equipment market in 2022. Western Europe was the second-largest region in global electrophysiology devices and equipment market share.The regions covered in the electrophysiology devices and equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the electrophysiology devices and equipment market are Brazil, China, France, Germany, India, Indonesia, Japan, South Korea, Russia, the UK, the USA, and Australia. The electrophysiology devices and equipment market consist of sales of ablation catheters, diagnostic catheters, mapping system, accessories, and other electrophysiology devices. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The electrophysiology devices and equipment market research report is one of a series of new reports from The Business Research Company that provides electrophysiology devices and equipment market statistics, including electrophysiology devices and equipment industry global market size, regional shares, competitors with a electrophysiology devices and equipment market share, detailed electrophysiology devices and equipment market segments, market trends and opportunities, and any further data you may need to thrive in the electrophysiology devices and equipment industry. This electrophysiology devices and equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

A medical electrodes transmit electricity from an instrument to a patient for treatment or surgery. Medical electrodes are used to measure internal ionic currents, which leads to the diagnosis of various ocular, nervous, cardiac, and muscular disorders. It is a key component in providing the appropriate amount of electrical contact between the device that records activity and the patient. These electrodes are made of metal, lead, and a gel or paste that conducts electricity. The main usability of medical electrodes is disposable medical electrodes and reusable medical electrodes. Disposable medical electrodes refer to the disposable medical electrode consisting of a disc made of a semi-rigid plastic substance with a centrally positioned recessed embossment. A metallic electrical contact with sections on both sides is put on the disc in the center of the embossment. Disposable electrodes can be used with snap-connect lead wires. Wet, dry, and needle electrodes are the technologies used. Electrocardiography, electroencephalography, and electromyography are the procedures where medical electrodes are used. Cardiology, neurophysiology, sleep disorders, and intraoperative monitoring are some applications of medical electrodes. The global medical electrodes market is segmented - 1) By Usability: Disposable Medical Electrodes, Reusable Medical Electrodes 2) By Technology: Wet Electrodes, Dry Electrodes, Needle Electrodes 3) By Procedure: Electrocardiography, Electroencephalography, Electromyography, Other Procedures 4) By Application: Cardiology, Neurophysiology, Sleep Disorders, Intraoperative Monitoring, Other Applications The global medical electrodes market size grew from $1.83 billion in 2022 to $1.97 billion in 2023 at a compound annual growth rate (CAGR) of 8.0%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of the global medical electrodes is expected to grow to $2.49 billion in 2027 at a CAGR of 6.0%. The increasing prevalence of chronic diseases is expected to propel the growth of the medical electrodes market. Chronic diseases are long-lasting sickness that often cannot be healed, however, it is occasionally curable and controllable. Chronic diseases are increasing due to the increasing use of tobacco products, poor nutrition, physical inactivity, excessive use of alcohol, and others. Medical electrodes treat chronic diseases by measuring, monitoring, and recording body functions such as heartbeat and brain waves during medications. According to a report published by American Action Forum in September 2020, chronic disease prevalence and costs are rising in the United States. They are expected to keep rising as the disease prevalence among children and young adults rises. Chronic disease is a serious healthcare problem since the rising cost of chronic disease in the United States totals $3.7 trillion annually, which is around 19.6% of the country's gross domestic product. Thus an increase in the prevalence of chronic diseases drives the growth of the medical electrodes market. Major players in the medical electrodes market are 3M Company, CONMED, Koninklijke Philips NV, Medtronic, Ambu A/S, Cognionics Inc., Natus Medical Incorporated, ZOLL Medical Corporation, Rhythmlink International LLC, GE Healthcare, Cooper Surgical Inc., Nissha Medical Technologies, Boston Scientific Corporation, Dymedix Diagnostics, Cardinal Health, B Braun Melsungen AG, Nihon Kohden Corporation and Thermo Fisher Scientific Inc. Technological advancement is a key trend gaining popularity in the medical electrodes market. The advancement of medical device electrodes is primarily focused on improving patient comfort and electrode-tissue interface for better recording and stimulation. The market is witnessing the demand for prominent electrodes such as electrocardiography electrodes, electroencephalography electrodes, and others. Major companies operating in the medical electrodes market are advancing new technologies and advanced medical electrodes products to strengthen their market position. For instance, in December 2021, Shin-Etsu Chemical Co., Ltd., a Tokyo-based chemical company, launched electrophysiological dry electrodes and high-elasticity wiring materials to help create performance traits for next wearable technology. While a person is wearing the wearable device on their body, it is possible to monitor and transmit their electrical bio signals from a distance, including vital indicators like heart rate and electrocardiogram (ECG) waveform. They assist people in enhancing their physical and mental well-being and will aid in the earlier detection and treatment of chronic disorders. In December 2020, Rhythmlink International, LLC, a US-based medical device manufacturing company, acquired Chalgren Enterprises for an undisclosed amount. With this acquisition, both companies would continue to grow the newly combined business while maintaining the integrity of both brands. Chalgren Enterprises is a US-based manufacturer of electrodes for neurodiagnostic, specializing in EMG electrodes. North America was the largest region in the medical electrodes market in 2022. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the medical electrodes market share report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the medical electrodes market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK and USA. The medical electrodes market consists of sales of electrocardiography (ECG) electrodes, fetal scalp electrodes, electroencephalography electrodes, transcutaneous electrical nerve stimulation TENS electrodes, and pacemaker electrodes. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The medical electrodes market research report is one of a series of new reports from The Business Research Company that provides medical electrodes market statistics, including medical electrodes industry global market size, regional shares, competitors with a medical electrodes market share, detailed medical electrodes market segments, market trends and opportunities, and any further data you may need to thrive in the medical electrodes industry. This medical electrodes market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Medical and diagnostic laboratory services are services that provide diagnostics tests for various diseases. The tests are used for detecting if the person has encountered the disease. Medical and diagnostic laboratory services makes it possible to deliver prompt, affordable, and high-quality diagnostic services in secure settings. The main types of medical and diagnostic laboratory services are diagnostic imaging centres and medical laboratory services. A diagnostic imaging center is a service provider that offers technical or comprehensive diagnostic imaging services. The different expenditure types include public and private that are used in various applications such as cardiology, oncology, neurology, orthopedics, gastroenterology, gynecology, and others. The services are used by males and females. The global medical and diagnostic laboratory services market is segmented - 1) By Type: Diagnostic Imaging Centers, Medical Laboratory Services 2) By Application: Cardiology, Oncology, Neurology, Orthopedics, Gastroenterology, Gynecology, Other Applications 3) By End User Gender: Male, Female 4) By Type of Expenditure: Public, Private Subsegments Covered: Computer Tomography (CT-Scan) Centers, Medical Radiological Laboratories, Dental or Medical X-Ray Laboratories, Ultrasound Imaging Centers, Magnetic Resonance Imaging (MRI) Centers The global medical and diagnostic laboratory services market grew from $169.87 billion in 2022 to $183.84 billion in 2023 at a compound annual growth rate (CAGR) of 8.2%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The medical and diagnostic laboratory services market is expected to grow to $240.86 billion in 2027 at a CAGR of 7.0%. The rise in sedentary jobs, busy lifestyles, and changing consumer preferences are affecting the disease profile of the world population, especially non-communicable diseases such as cancer, diabetes, and cardiovascular diseases. Long working hours, less physical activity, and unhealthy eating and drinking habits are major causes of chronic diseases such as diabetes. According to the World Health Organization, chronic disease prevalence rose by 57% globally, in 2020. Tests to diagnose these diseases include HbA1c tests for monitoring diabetes, biopsies, tumor marker tests, bone scans, MRI and CT scans for diagnosis of various cancers, electrocardiograms, chest X-rays, cardiac CT scans, and stress tests for detection of cardiovascular diseases. The increase in the prevalence of lifestyle diseases will increase the demand for tests to diagnose these diseases and thus will drive the medical and diagnostic laboratory services market during the forecast period. Major companies in the medical and diagnostic laboratory services market include Laboratory Corporation of America, Eurofins, Quest Diagnostics Incorporated, Sonic Healthcare Limited, Kaiser Permanente, RadNet, OPKO Health, Myriad Genetics, Charles River Laboratories, Inc., and NeoGenomics Laboratories, Inc. The medical and diagnostic laboratory services market is expected to limit by the rising prevalence of self-care diagnostic equipment. These tools can be used by patients without assistance from medical personnel, to diagnose particular disabilities or disorders. Common self-care diagnostic devices include glucose monitoring devices, blood pressure monitoring devices, sleep apnea monitors and temperature monitors. The ease of use of self-care devices has increased demand for them during the last decade and is expected to increase it further during the forecast period. Some virtual applications are also aiding in the diagnosis of certain health conditions. For instance, iPhone is working on an IOS accessory called Cue, which can be used as a home diagnostic kit. Self-care diagnostics is expected to have a negative impact on the traditional medical and diagnostic laboratory services market during the forecast period by reducing the need for laboratory testing for some basic tests. Medical and diagnostic laboratories are using biomarkers to measure health parameters associated with individual wellness. The health and well-being of individuals can be measured by using biomarkers to assess factors behind sleep disorders and symptoms of stress. Biomarkers such as cortisol, testosterone, and secretory IgA can indicate changes in the immune system relating to physical and mental conditions. This can be used by physicians to know the causative factors behind such conditions. This is a premium service primarily targeted at wealthy individuals and senior employees of corporations. North America was the largest region in the medical and diagnostic laboratory services market in 2022. Asia-Pacific was the second largest region in the medical and diagnostic laboratory services market. The regions covered in the medical and diagnostic laboratory services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the medical and diagnostic laboratory services market are Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Hong Kong, India, Indonesia, Ireland, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, New Zealand, Nigeria, Norway, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, South Africa, South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, UAE, UK, USA, Venezuela, and Vietnam. The medical and diagnostic laboratory services market includes revenues earned by entities by providing diagnostic services such as diagnostic laboratory services, X-ray, CT scan, and Mammography. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The medical and diagnostic laboratory services market research report is one of a series of new reports from The Business Research Company that provides medical and diagnostic laboratory services market statistics, including medical and diagnostic laboratory services industry global market size, regional shares, competitors with a medical and diagnostic laboratory services market share, detailed medical and diagnostic laboratory services market segments, market trends and opportunities, and any further data you may need to thrive in the medical and diagnostic laboratory services industry. This medical and diagnostic laboratory services market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Disposable hospital supplies are medical devices that are only intended for one-time use.These products are essential components in hospitals as these devices save time and reduce health-related costs. The main types of disposable hospital supplies are gloves, drapes, gowns, needles, syringes, procedure kits and trays, bandages, and masks. The drapes are to be covered or adorned with or as if with cloth folds. The products used are diagnostic supplies, dialysis consumables, radiology consumables, infusion products, incubation and ventilation supplies, hypodermic products, sterilization consumables, non-woven medical supplies, wound care consumables, and others. The various end-users are hospitals, clinics/physician offices, assisted living centres, nursing homes, ambulatory surgery centres, and research institutes. The global disposable hospital supplies market is segmented - 1) By Type: Gloves, Drapes, Gowns, Needles, Syringes, Procedure Kits And Trays, Bandages, Masks 2) By Product: Diagnostic Supplies, Dialysis Consumables, Radiology Consumables, Infusion Products, Incubation & Ventilation Supplies, Hypodermic Products, Sterilization Consumables, Non-Woven Medical Supplies, Wound Care Consumables, Other Products 3) By End-Users: Hospitals, Clinics/Physician Offices, Assisted Living Centers & Nursing Homes, Ambulatory Surgery Centers, Research Institutes The global disposable hospital supplies market size will grow from $27.97 billion in 2022 to $29.7 billion in 2023 at a compound annual growth rate (CAGR) of 6.2%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of global disposable hospital supplies is expected to grow to $36.29 billion in 2027 at a CAGR of 5.1%. The increasing number of COVID-19 cases across the globe is projected to surge the demand for disposable hospital supplies. The rapid surge in coronavirus cases is generating huge demand for personal protective equipment (PPE) and other disposable supplies to protect healthcare workers from infections in their daily operations. According to the World Health Organization report published on the 3rd of July 2020, there were 10,719,946 COVID-19 confirmed cases including 323,412 deaths globally. Therefore, the rise in the number of cases across the globe and the growing need for healthcare workers to be protected against the spread of the virus are anticipated to boost the demand for the disposable hospital supplies market over the forecast period. Major players in the disposable hospital supplies market are Abbott Laboratories, Bayer AG, Becton, Dickinson and Company, Cardinal Health Incorporated, Domtar Corporation, 3M, Stryker Corp., Hill-Rom Holdings Inc., Steris Corp., and Getinge AB. Government agencies are extending support to PPE manufacturers and suppliers to ensure the smooth flow of medical supplies. For instance, UNICEF launched a joint tender in April for PPE supplies during 2020 on behalf of several UN organizations. The government initiatives to help medical supplies manufacturers and suppliers are likely to play a vital role in aiding the manufacture of essential medical supplies, which in turn, is predicted to shape the disposable hospital supplies market in the forthcoming years. Rising environmental concerns associated with the improper disposal of non-reusable hospital supplies are expected to limit the growth of the disposable hospital supplies market. In healthcare facilities, disposable gloves and gowns are widely used to maintain a sterile environment and reduce the risk of spreading infections during the pandemic. Improper disposal of supplies including gloves, gowns, masks, and other personal protective equipment used during the monitoring and treatment of COVID-affected patients poses a high risk of virus spread. Environmental regulatory bodies are imposing stringent rules for the proper and managed disposal of hospital wastes. For instance, in the USA, contaminated gloves are disposed of in orange-lidded containers or orange bags based on the law guidance laid by the Royal College of Nursing. The increase in production capacities by various players dealing in the disposable hospital supplies market amid coronavirus outbreaks is a leading trend shaping the growth of the industry. For instance, on 15th May 2020, Honeywell announced plans to build a new production line in Scotland, UK with the capacity of producing 4.5 million FFP3 and FFP2 disposable face masks every month. These masks are likely to assist the UK government’s response to the COVID-19 outbreak. Thus, the expansion of production capacities to meet the increased demand for disposable medical supplies is projected to generate higher revenues for the market during 2020. In April 2020, Eclipse Automation Inc. announced a collaboration with Harmontronics Automation of Suzhou, China to manufacture, distribute and sell the Harmontronics fully automated N95 Vertical Flat-Fold Respirator Mask production line system across North America. Harmontronics Automation is a factory automation solution provider for small and precise product manufacturing. North America was the largest region in the disposable hospital supplies market in 2022. Western Europe was the second largest region in the disposable hospital supplies market report. The regions covered in the disposable hospital supplies industry report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the disposable hospital supplies market are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA. The disposable hospital supplies market consists of sales of procedure kits and trays, conventional syringes and needles, facemasks, prefilled syringes, isolation gowns, and medical gloves that are used in dental hospitals. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The disposable hospital supplies market research report is one of a series of new reports from The Business Research Company that provides disposable hospital supplies market statistics, including disposable hospital supplies industry global market size, regional shares, competitors with a disposable hospital supplies market share, detailed disposable hospital supplies market segments, market trends and opportunities, and any further data you may need to thrive in the disposable hospital supplies industry. This disposable hospital supplies market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

3D printed medical devices are artificial devices that replace a missing body part or biological structure and are manufactured by laying successive layers of material using inputs from a digital 3D model. The main types of 3D printed medical devices are implants, surgical instruments, prosthetics, tissue engineering devices, and others. The 3D-printed implants are medical implants that are made using 3D printing technology to create complex geometries. These are made up of raw materials such as plastics, biomaterial inks, and metals and alloys. The technologies involved in 3D printed medical devices are fused deposition modeling, digital light processing, stereolithography, and selective laser melting. These provide applications in orthopedic, spinal, dental, hearing aids, and others that are used by end-users such as hospitals, diagnostics centres, academic institutions, and others. The global 3D printed medical devices market is segmented – 1) By Type: Implants, Surgical instruments, Prosthetics, Tissue engineering devices, Other Types 2) By Application: Orthopedic, Spinal, Dental, Hearing Aids, Other Applications 3) By Technology: Fused Deposition Modelling, Digital Light Processing, Stereolithography, Selective Laser melting 4) By Raw Material: Plastics, Biomaterial inks, Metals and Alloys 5) By End User: Hospitals, Diagnostics Centres, Academic Institutions, Other End Users The global 3d printed medical devices market size grew from $2.87 billion in 2022 to $3.57 billion in 2023 at a compound annual growth rate (CAGR) of 24.5%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of global 3d printed medical devices is expected to grow to $9.09 billion in 2027 at a CAGR of 26.3%. The increasing prevalence of osteoarthritis and similar musculoskeletal conditions is one of the major factors driving the growth of the 3D printed medical devices market. Osteoarthritis is a disorder that damages the joint cartilage and surrounding tissues causing pain, stiffness, and loss of joint function to the person affected by it. The 3D printing medical devices enable the creation of a replica of a patient's joint, which can provide surgeons with a crucial piece of information that might not be visible on a 2-dimensional scan. The chance of developing osteoarthritis increases with age. For instance, according to the US National Library of Medicine report, by 2040, it is estimated that approximately 78 million (26%) US adults aged 18 years and above will be projected to have doctor-diagnosed arthritis. Thereby driving the adoption of 3D printed medical devices, positively impacting the 3d printed medical devices market growth. Major players in the 3D printed medical devices market are 3D Systems Corporation, EnvisionTEC, Stratasys Ltd., Arcam AB, Cyfuse Biomedical, Materialise NV, Organovo Holdings, EOS GmbH, FabRx Ltd., and Concept Laser. Biocompatibility issues related to 3D printed medical devices restrict the growth of the 3D printed medical devices market. Biocompatibility implies the properties that make a material or a device compatible with the human body. If the material used for the preparation of a 3D printed implant device is not compatible with the patients' biomechanics, then patients may suffer side effects such as abnormal growth of bone and bleeding. Among the most common metal used in the manufacturing of 3D printed medical devices is Titanium. Though Titanium offers reliability and accuracy in creating medical-grade products, some human bodies tend to reject titanium as its chemical composition can inhibit the bone and tissue from interacting with the implant. Apart from these other reasons which may contribute to the failure of metallic implants that are either caused by the material properties of the metal (e.g., high stiffness, high corrosion rate, and toxicity) itself or by the exposure of the bone to infected metal implants i.e., infection. The increasing use of 3D printing technology in the spine industry is one of the latest trends in the 3D printed medical devices market. The spine industry is adopting 3D printing to produce new innovative products that can promote bone ingrowth and improve implant fixation to spine bone, reducing the number of manufacturing steps, thereby making the 3D printing process more cost-effective in several cases. For instance, Medtronic launched its titanium 3D printed platform – TiONIC Technology. TiONIC Technology is a 3D printed technique that uses laser methods to create implants with enhanced surface textures. Artic-L is the first implant created by the company using TiONIC Technology. The implant is made up of titanium and is designed to be used by surgeons in spine surgery. In addition to that, K2M’s Lamellar, introduced its 3D Titanium Technology to create a 3D spinal implant. The 3D printing medical device using titanium technology uses an advanced 3D printing method to create structures that were once considered impractical with traditional manufacturing techniques. The implants use titanium powder and are associated with bone growth activity. Food and Drug Administration (FDA) has a Centre for Device and Radiological Health (CDRH) to regulate the firm which manufacture, repackage, relabel and/or import 3D printing medical devices in the US. FDA provides manufacturers with a draft with guidance that includes recommendations for device design, manufacturing, and testing considerations during the development of 3D printing medical devices. Section F of the 'Technical Considerations for Additive Manufactured Medical Device' draft, requires the manufacturers to evaluate the biocompatibility of the final finished device as described in the guidance "Use of International Standard ISO-10993". The guidelines also require the manufacturer of the 3D printing devices to mention the additional information in the label if any toxic chemical additives such as certain additives, catalysts, binding and curing agents, uncured monomers, and plasticizers are used in making 3D printing medical devices. In July 2020, Medtronic, an American Irish-domiciled medical device company acquired Medicrea International for an undisclosed amount. The acquisition of Medicrea expands Medtronic’s already deep portfolio as this adds to their spinal solution profile as the advent of new digital technology will offer the ability to custom spinal implants. Medicrea International is a spinal surgery company with 30+ FDA-approved spinal implant technologies that have been utilized in over 150,000 spinal surgeries to date. North America was the largest region in the 3D printed medical devices market in 2022. Western Europe was the second largest region in the 3D printed medical devices market. The regions covered in the 3D printed medical devices market analysis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the 3D printed medical devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA. The 3D printed medical devices market consists of sales of 3D printed prosthetics and implants. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The 3D printed medical devices market research report is one of a series of new reports from The Business Research Company that provides 3D printed medical devices market statistics, including 3D printed medical devices industry global market size, regional shares, competitors with a 3D printed medical devices market share, detailed 3D printed medical devices market segments, market trends and opportunities, and any further data you may need to thrive in the 3D printed medical devices industry. This 3D printed medical devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Veterinary medical equipment refers to types of medical devices and surgical equipment such as endoscopic systems, dental equipment, and veterinary telemetry services that are used for operations, therapy, keeping track of diagnoses and vitals, and enhancing animal care to slow down the progression of diseases. The main types of veterinary medical equipment are veterinary diagnostic equipment, veterinary anaesthesia equipment, veterinary patient monitoring equipment, and other veterinary medical equipment that is used for animals such as small companion animals, large animals, and other animals. Veterinary anaesthesia equipment refers to the equipment that is used for animals to provide anesthesia. The products used are instruments, equipment, and disposables. These are used in veterinary hospitals, veterinary clinics, and research institutes. The global veterinary medical equipment market is segmented - 1) By Type: Veterinary Diagnostic Equipment, Veterinary Anesthesia Equipment, Veterinary Patient Monitoring Equipment, Other Veterinary Medical Equipment 2) By Product: Instruments/Equipment, Disposables 3) By Animal Type: Small Companion Animals, Large Animals, Other Animals 4) By End User: Veterinary Hospitals, Veterinary Clinics, Research Institutes The global veterinary medical equipment market size will grow from $2.25 billion in 2022 to $2.42 billion in 2023 at a compound annual growth rate (CAGR) of 7.7%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, surge in commodity prices, and supply chain disruptions, and affecting many markets across the globe. The market size of veterinary medical equipment is expected to grow from $3.15 billion in 2027 at a CAGR of 6.8%. The global economy is expected to go through a continued period of steady growth during the forecast period. The US economy showed steady growth during the historic period, and this is likely to continue during the forecast period. Emerging markets reached 4.8% in 2020 versus 3.6% in 2019. The continued economic growth is expected to contribute to increased standards of living of the global population and strengthen the presence of the middle class. Increased standards of living and a strengthened middle class will further drive the demand for improved nutrition, particularly animal protein, and increase focus on food quality and safety, supporting the growth of the animal medicine market in terms of feed additives. Thus, economic growth is expected to drive this market. Major companies in the veterinary medical equipment market include Carestream Health, IDEXX Laboratories Inc., Agfa Healthcare, MinXray Inc., and Diagnostic Imaging Systems. The outbreak of COVID-19 disease (COVID-19) has acted as a massive restraint on the veterinary medical equipment market in 2020 as supply chains were disrupted due to trade restrictions and consumption declined due to lockdowns imposed by governments globally. COVID-19 is an infectious disease with flu-like symptoms including fever, cough, and difficulty breathing. The virus was first identified in 2019 in Wuhan, Hubei province of the People’s Republic of China, and has spread globally, including Western Europe, North America, and Asia. Steps by national governments to contain the transmission have resulted in a decline in economic activity with countries entering a state of "lock down" and the outbreak hurting businesses throughout 2020 and into 2021. However, it is expected that the veterinary medical equipment market will recover from the shock across the forecast period as it is a "black swan" event and not related to ongoing or fundamental weaknesses in the market or the global economy. Advances in diagnostic tools have improved veterinary services. Equipment such as portable x-ray and portable ultrasound scanners has increased the efficiency of veterinary treatment (especially in emergencies due to injury) for all equine/large animals, companions, exotic and mixed animal practices. For example, Wristscan V9, a diagnostic device, is being used for pregnancy tests for animals. In addition, the Alivecor iPhone app is used to perform electrocardiograms on animals for cardiologist review. North America was the largest region in the veterinary medical equipment market in 2022. Asia-Pacific was the second-largest region in the veterinary medical equipment market share. The regions covered in the veterinary medical equipment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the veterinary medical equipment market include Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Hong Kong, India, Indonesia, Ireland, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, New Zealand, Nigeria, Norway, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, South Africa, South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, UAE, UK, USA, Venezuela, and Vietnam. The veterinary medical equipment market consists of sales of stethoscopes, ultrasounds, x-ray machines, sonography machines, and intravenous pumps. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The veterinary medical equipment research report is one of a series of new reports from The Business Research Company that provides veterinary medical equipment statistics, including veterinary medical equipment industry global market size, regional shares, competitors with veterinary medical equipment shares, detailed veterinary medical equipment segments, market trends and opportunities, and any further data you may need to thrive in the veterinary medical equipment industry. This veterinary medical equipment research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.